Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trial

Back

EHRA Premium Access

Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trial

Session: Atrial fibrillation: clinical 1

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor A. Benz (Hamilton, CA)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Philipp Benz

Population Health Research Institute, Hamilton (Canada)

0 follower

6 more presentations in this session

Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort

Speaker: Doctor W. McIntyre (Hamilton, CA)

Dietary sodium intake and atrial myopathy

Speaker: Associate Professor L. Johnson (Malmo, SE)

Assessing heart rate fragmentation to predict atrial fibrillation in the general population aged 65

Speaker: Doctor J. Guichard (Barcelona, ES)

Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness

Speaker: Doctor W. McIntyre (Hamilton, CA)

Quality of life when switching from a vitamin K antagonist to non-vitamin K antagonist oral anticoagulation in frail older patients with atrial fibrillation

Speaker: Doctor S. van Doorn (Utrecht, NL)

Access the full session

Atrial fibrillation: clinical 1

Speakers: Doctor A. Benz, Doctor W. McIntyre, Associate Professor L. Johnson, Doctor J. Guichard, Doctor W. McIntyre...

Access

Video

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources